SPD-473

N/A

Report date: 2022/03/01 14:05:32
NME

Base Information

Drug NameSPD-473
Drug Alias NameBTS-74398SPD-473
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsDopamine reuptake inhibitorsAdrenergic receptors antagonists
TargetsDopamine transporterSerotonin transporterAdrenergic receptors
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire PharmaceuticalsAbbvie Inc
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityDepression

Other Information

ATC CodeN/A
Related LinksN/A